H2ocean Donates 150,000+ Bottles Of Sea Salt-Based Healing Rinse To Promote Natural Oral Care Solutions Globally
H2Ocean- First in First Aid Eddie Kolos, CEO, dispatches H2Ocean Healing Rinse Mouthwash to non <a target=_blank href= ...
newsworthy8d
Iotech International Launches ioRinseâ„¢MR: A Revolutionary Oral Rinse Providing Profound Relief For Cancer Patients Facing Oral Side Effects
Leveraging ioTech’s proprietary molecular iodine technology, ioRinse™ MR provides substantial relief for cancer patients ...
Yahoo Finance15d
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Dusquetide, the active ingredient in SGX945 (Behçet's Disease) and SGX942 (oral mucositis), is an innate defense regulator ...
Nasdaq15d
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Schaber, PhD, President and Chief Executive Officer of Soligenix. "Our previous studies with dusquetide in oral mucositis have validated the biologic activity in aphthous ulcers induced by ...
AOL15d
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Dusquetide, the active ingredient in SGX945 (Behçet's Disease) and SGX942 (oral mucositis), is an innate defense regulator (IDR), a new class of short, synthetic peptides. Dusquetide has ...
Medscape1mon
Prevention and Treatment of Oropharyngeal Mucositis Following Cancer Therapy: Are There New Approaches?
Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head and neck irradiation. This oral sequela significantly impairs the daily functioning and quality of life of ...
Pharmabiz1mon
Jaguar Health introduces US FDA-approved oral mucositis prescription product Gelclair in US
Jaguar Health, Inc. announced that Jaguar family company Napo Pharmaceuticals (Napo) has initiated the commercial launch of the FDA-approved oral mucositis prescription product Gelclair in the US.